Skip to main content


2021 Hybrid Event
October 19-23, 2021
New York City, NY or Online

Recognized as one of the most respected forums for industry-leading hematologic research and clinical case studies, the Lymphoma, Leukemia and Myeloma Congress is the meeting where interdisciplinary specialists convene to explore the controversial and complex world of blood cancer through debate, discussion and networking.

On-demand access will be available for 3 months after the meeting has ended. 

Engaged Crowd

This not to miss dynamic program features 4 days of comprehensive learning as we analyze emerging data, discover innovative treatment methods, and get a glimpse into the future of lymphoma, myeloma, and leukemia disorders.


Years of Innovation
Expert Faculty
Credit Hours
Who Should Attend?

This live, CME activity is designed to meet the educational needs of those who are involved and/or interested in the treatment of patients with hematologic malignancies. 25+ Credit Hours are available!

Medical oncologists
Physician assistants
Oncology nurses
Nurse practitioners
Meet the Chairs
Congress Chair
Morton Coleman, MD
Weill Cornell Medicine
New York, NY
Richard R. Furman, MD
Weill Cornell Medicine
New York, NY
John P. Leonard, MD
Weill Cornell Medicine
New York, NY
Ruben Niesvizky, MD
Weill Cornell Medicine
New York, NY
Gail J. Roboz, MD
Weill Cornell Medicine
New York, NY
Jeremy Heinerich, PA-C
Mount Sinai Hospital/
NYP Weill Cornell Medical Center
New York, NY
The concentration of clinical treatment, prognostic and biologic advances in lymphoma, myeloma and CLL, and how they impact on current practice care is the key strength and takeaway. Having key clinical and translational researchers talk in the same session for a detailed Q&A panel is also very unique and helpful."

Neil Kay, MD
Division of Hematology
Department of Internal Medicine
Mayo Clinic

Lymphoma & Myeloma is genuinely one of the best meetings of the year. The detailed agenda allows for a deep dive into these complex diseases and provides practical advice to the treating clinician. The time allowed for Q&A makes this program unique, facilitating excellent interaction with the faculty, who are truly the leaders in the field. A mix of debates and didactic lectures keeps the audience engaged and encourages outstanding education."

Joseph Mikhael, MD
Chief Medical Officer
International Myeloma Foundation

The Lymphoma and Myeloma conference offers an up to the minute pithy overview of the important issues in managing lymphoma and myeloma patients. As someone who doesn’t see many different types of blood cancer patients, I highly recommend it as a fast-paced way to get a thorough review or refresh."

Brian Koffman, MDCM DCFP, DABFM, MS Ed
Co-Founder, Executive VP and Chief Medical Officer
Chronic Lymphocytic Lymphoma Society


Keep Me Informed